#KO
### ğŸ’Š ì§€ì—˜ì„¸í‹°ë¦¬ì§„ì—¼ì‚°ì—¼ì • - íš¨ëŠ¥ ë° íš¨ê³¼
* ì´ ì•½ì€ ê³„ì ˆì„± ë° ë‹¤ë…„ì„± ì•Œë ˆë¥´ê¸°ì„± ë¹„ì—¼, ì•Œë ˆë¥´ê¸°ì„± ê²°ë§‰ì—¼, ë§Œì„± íŠ¹ë°œì„± ë‘ë“œëŸ¬ê¸°, í”¼ë¶€ê°€ë ¤ì›€ì¦ê³¼Â í•˜ì´ë“œë¡œì½”í‹°ì† ì™¸ìš©ì œì™€ ë³‘ìš©ì— ì˜í•œ ìŠµì§„, í”¼ë¶€ì—¼ì— ì‚¬ìš©í•©ë‹ˆë‹¤.

### ğŸ•’ ì§€ì—˜ì„¸í‹°ë¦¬ì§„ì—¼ì‚°ì—¼ì • - ìš©ë²• ë° ìš©ëŸ‰
* ì„±ì¸ ë° 6ì„¸ ì´ìƒì˜ ì†Œì•„ëŠ” 1ì¼ 1íšŒ 1ì •(10 mg)ì„ ì·¨ì¹¨ ì „ì— ë³µìš©í•˜ê³ , ì´ìƒë°˜ì‘ì— ë¯¼ê°í•œ í™˜ìì˜ ê²½ìš°ëŠ”Â 1/2ì •(5 mg)ì”©ì„ ì•„ì¹¨, ì €ë…ì— ë¶„í•  ë³µìš©í•©ë‹ˆë‹¤.

ì—°ë ¹, ì¦ìƒì— ë”°ë¼ ì ì ˆíˆ ì¦ê°í•©ë‹ˆë‹¤.

ì‹ ì¥ì•  í™˜ìì˜ íˆ¬ì—¬ ê°„ê²©ì€ í™˜ìì˜ ì‹ ê¸°ëŠ¥ì— ë”°ë¼ ì¡°ì ˆë˜ì–´ì•¼ í•˜ê³ , ì‹ ì¥ì• ë¥¼ ê°€ì§„ ì†Œì•„ í™˜ìëŠ” í™˜ìì˜ ì‹  ì²­ì†Œìœ¨ê³¼ ì²´ì¤‘ì„ ê³ ë ¤í•˜ì—¬ ê°œë³„ì ìœ¼ë¡œ ìš©ëŸ‰ì„ ì¡°ì ˆí•´ì•¼ í•˜ë¯€ë¡œ ìì„¸í•œ ì‚¬í•­ì€ í—ˆê°€ì‚¬í•­ì„ ì°¸ê³ í•˜ì‹­ì‹œì˜¤.

### âš ï¸ ì§€ì—˜ì„¸í‹°ë¦¬ì§„ì—¼ì‚°ì—¼ì • - ì£¼ì˜ì‚¬í•­
* ì •ë³´ ì—†ìŒ
* ì´ ì•½ ë°Â íˆë“œë¡ì‹œì§„ ë˜ëŠ” í”¼í˜ë¼ì§„ ìœ ë„ì²´ì— ê³¼ë¯¼ì¦ í™˜ì, ì‹ ë¶€ì „ í™˜ì(í¬ë ˆì•„í‹°ë‹Œ ì²­ì†Œìœ¨ 

ì´ ì•½ì„ ë³µìš©í•˜ê¸° ì „ì— ì„ë¶€, ìˆ˜ìœ ë¶€, ì‹ ì¥ì• (ì‹ ì¥ì¥ì• ), ê°„ì¥ì•  í™˜ì, ë…¸ì¸, ë‡Œì „ì¦ í™˜ì ë° ë°œì‘ ìœ„í—˜ì„±ì´ ìˆëŠ” í™˜ì,Â ì†Œë³€ê³ ì„ì˜ ì„ í–‰ìš”ì¸(ì²™ìˆ˜ ë³‘ë³€, ì „ë¦½ì„  ë¹„ëŒ€ì¦)ì´ ìˆëŠ” í™˜ìëŠ” ì˜ì‚¬ ë˜ëŠ” ì•½ì‚¬ì™€ ìƒì˜í•˜ì‹­ì‹œì˜¤.

#EN
### ğŸ’Š ì§€ì—˜ì„¸í‹°ë¦¬ì§„ì—¼ì‚°ì—¼ì • - Efficacy and Effects
*   This drug is used for seasonal and perennial allergic rhinitis, allergic conjunctivitis, chronic idiopathic urticaria, pruritus (itchy skin), and in combination with hydrocortisone topical preparations for eczema and dermatitis.

### ğŸ•’ ì§€ì—˜ì„¸í‹°ë¦¬ì§„ì—¼ì‚°ì—¼ì • - Dosage and Administration
*   Adults and children aged 6 years and older should take 1 tablet (10 mg) once daily before bedtime. For patients sensitive to adverse reactions, take 1/2 tablet (5 mg) each in the morning and evening, divided doses.
    The dosage may be adjusted appropriately depending on age and symptoms.
    The dosing interval for patients with renal impairment should be adjusted according to the patient's renal function. For pediatric patients with renal impairment, the dose should be individually adjusted considering the patient's creatinine clearance and body weight. Please refer to the approved product information for detailed instructions.

### âš ï¸ ì§€ì—˜ì„¸í‹°ë¦¬ì§„ì—¼ì‚°ì—¼ì • - Precautions
*   No information
*   This drug is contraindicated in patients with hypersensitivity to this drug, hydroxyzine, or piperazine derivatives, and in patients with severe renal failure (creatinine clearance < 10 mL/min).
*   Before taking this drug, pregnant or lactating women, patients with renal impairment, hepatic impairment, elderly patients, epileptic patients or those at risk of seizures, and patients with predisposing factors for urinary retention (e.g., spinal cord lesion, prostatic hyperplasia) should consult a doctor or pharmacist.

---

#CN
### ğŸ’Š ì§€ì—˜ì„¸í‹°ë¦¬ì§„ì—¼ì‚°ì—¼ì • - åŠŸæ•ˆä¸ä½œç”¨
*   æœ¬è¯ç”¨äºæ²»ç–—å­£èŠ‚æ€§å’Œå¸¸å¹´æ€§è¿‡æ•æ€§é¼»ç‚ã€è¿‡æ•æ€§ç»“è†œç‚ã€æ…¢æ€§ç‰¹å‘æ€§è¨éº»ç–¹ã€çš®è‚¤ç˜™ç—’ç—‡ï¼Œä»¥åŠä¸æ°¢åŒ–å¯çš„æ¾å¤–ç”¨åˆ¶å‰‚è”åˆç”¨äºæ¹¿ç–¹å’Œçš®ç‚ã€‚

### ğŸ•’ ì§€ì—˜ì„¸í‹°ë¦¬ì§„ì—¼ì‚°ì—¼ì • - ç”¨æ³•ä¸ç”¨é‡
*   æˆäººåŠ6å²ä»¥ä¸Šå„¿ç«¥æ¯æ—¥ä¸€æ¬¡ï¼Œç¡å‰æœç”¨1ç‰‡ï¼ˆ10æ¯«å…‹ï¼‰ã€‚å¯¹ä¸è‰¯ååº”æ•æ„Ÿçš„æ‚£è€…ï¼Œå¯å°†1/2ç‰‡ï¼ˆ5æ¯«å…‹ï¼‰åˆ†æ—©æ™šæœç”¨ã€‚
    æ ¹æ®å¹´é¾„å’Œç—‡çŠ¶å¯é€‚å½“å¢å‡å‰‚é‡ã€‚
    è‚¾åŠŸèƒ½ä¸å…¨æ‚£è€…çš„ç»™è¯é—´éš”åº”æ ¹æ®æ‚£è€…çš„è‚¾åŠŸèƒ½è¿›è¡Œè°ƒæ•´ã€‚å¯¹äºæ‚£æœ‰è‚¾åŠŸèƒ½ä¸å…¨çš„å„¿ç«¥æ‚£è€…ï¼Œåº”æ ¹æ®æ‚£è€…çš„è‚¾æ¸…é™¤ç‡å’Œä½“é‡ä¸ªä½“åŒ–è°ƒæ•´å‰‚é‡ï¼Œè¯¦ç»†ä¿¡æ¯è¯·å‚è€ƒè¯å“è¯´æ˜ä¹¦ã€‚

### âš ï¸ ì§€ì—˜ì„¸í‹°ë¦¬ì§„ì—¼ì‚°ì—¼ì • - æ³¨æ„äº‹é¡¹
*   æ— ä¿¡æ¯
*   æœ¬è¯ç¦ç”¨äºå¯¹æ­¤è¯ã€ç¾Ÿå—ªæˆ–å“Œå—ªè¡ç”Ÿç‰©è¿‡æ•çš„æ‚£è€…ï¼Œä»¥åŠä¸¥é‡è‚¾åŠŸèƒ½ä¸å…¨æ‚£è€…ï¼ˆè‚Œé…æ¸…é™¤ç‡ < 10 mL/minï¼‰ã€‚
*   åœ¨æœç”¨æœ¬è¯å‰ï¼Œå­•å¦‡ã€å“ºä¹³æœŸå¦‡å¥³ã€è‚¾åŠŸèƒ½æŸå®³æ‚£è€…ã€è‚åŠŸèƒ½æŸå®³æ‚£è€…ã€è€å¹´äººã€ç™«ç—«æ‚£è€…åŠæœ‰ç™«ç—«å‘ä½œé£é™©çš„æ‚£è€…ï¼Œä»¥åŠæœ‰å°¿æ½´ç•™è¯±å› ï¼ˆå¦‚è„Šé«“ç—…å˜ã€å‰åˆ—è…ºå¢ç”Ÿï¼‰çš„æ‚£è€…ï¼Œåº”å’¨è¯¢åŒ»ç”Ÿæˆ–è¯å¸ˆã€‚

---

#JP
### ğŸ’Š ì§€ì—˜ì„¸í‹°ë¦¬ì§„ì—¼ì‚°ì—¼ì • - åŠ¹èƒ½ãƒ»åŠ¹æœ
*   æœ¬å‰¤ã¯ã€å­£ç¯€æ€§ãŠã‚ˆã³é€šå¹´æ€§ã‚¢ãƒ¬ãƒ«ã‚®ãƒ¼æ€§é¼»ç‚ã€ã‚¢ãƒ¬ãƒ«ã‚®ãƒ¼æ€§çµè†œç‚ã€æ…¢æ€§ç‰¹ç™ºæ€§è•éº»ç–¹ã€çš®è†šãã†ç—’ç—‡ã€ãªã‚‰ã³ã«ãƒ’ãƒ‰ãƒ­ã‚³ãƒ«ãƒã‚¾ãƒ³å¤–ç”¨å‰¤ã¨ã®ä½µç”¨ã«ã‚ˆã‚‹æ¹¿ç–¹ã€çš®è†šç‚ã«ç”¨ã„ã‚‰ã‚Œã¾ã™ã€‚

### ğŸ•’ ì§€ì—˜ì„¸í‹°ë¦¬ì§„ì—¼ì‚°ì—¼ì • - ç”¨æ³•ãƒ»ç”¨é‡
*   æˆäººãŠã‚ˆã³6æ­³ä»¥ä¸Šã®å°å…ã¯ã€1æ—¥1å›1éŒ ï¼ˆ10mgï¼‰ã‚’å°±å¯å‰ã«æœç”¨ã—ã€å‰¯ä½œç”¨ã«æ•æ„Ÿãªæ‚£è€…ã®å ´åˆã¯ã€1/2éŒ ï¼ˆ5mgï¼‰ãšã¤ã‚’æœã€å¤•ã«åˆ†å‰²ã—ã¦æœç”¨ã—ã¾ã™ã€‚
    å¹´é½¢ã€ç—‡çŠ¶ã«å¿œã˜ã¦é©å®œå¢—æ¸›ã—ã¾ã™ã€‚
    è…æ©Ÿèƒ½éšœå®³æ‚£è€…ã®æŠ•ä¸é–“éš”ã¯ã€æ‚£è€…ã®è…æ©Ÿèƒ½ã«å¿œã˜ã¦èª¿æ•´ã•ã‚Œã‚‹ã¹ãã§ã‚ã‚Šã€è…æ©Ÿèƒ½éšœå®³ã‚’æŒã¤å°å…æ‚£è€…ã¯ã€æ‚£è€…ã®ã‚¯ãƒ¬ã‚¢ãƒãƒ‹ãƒ³ã‚¯ãƒªã‚¢ãƒ©ãƒ³ã‚¹ã¨ä½“é‡ã‚’è€ƒæ…®ã—ã¦å€‹åˆ¥ã«ç”¨é‡ã‚’èª¿æ•´ã™ã‚‹å¿…è¦ãŒã‚ã‚‹ãŸã‚ã€è©³ç´°ã«ã¤ã„ã¦ã¯æ·»ä»˜æ–‡æ›¸ã‚’å‚ç…§ã—ã¦ãã ã•ã„ã€‚

### âš ï¸ ì§€ì—˜ì„¸í‹°ë¦¬ì§„ì—¼ì‚°ì—¼ì • - æ³¨æ„äº‹é …
*   æƒ…å ±ãªã—
*   æœ¬å‰¤ãŠã‚ˆã³ãƒ’ãƒ‰ãƒ­ã‚­ã‚·ã‚¸ãƒ³ã¾ãŸã¯ãƒ”ãƒšãƒ©ã‚¸ãƒ³èª˜å°ä½“ã«å¯¾ã—éæ•ç—‡ã®æ—¢å¾€æ­´ã®ã‚ã‚‹æ‚£è€…ã€é‡åº¦ã®è…ä¸å…¨æ‚£è€…ï¼ˆã‚¯ãƒ¬ã‚¢ãƒãƒ‹ãƒ³ã‚¯ãƒªã‚¢ãƒ©ãƒ³ã‚¹ < 10 mL/minï¼‰ã«ã¯ç¦å¿Œã§ã™ã€‚
*   æœ¬å‰¤ã‚’æœç”¨ã™ã‚‹å‰ã«ã€å¦Šå©¦ã€æˆä¹³å©¦ã€è…æ©Ÿèƒ½éšœå®³æ‚£è€…ã€è‚æ©Ÿèƒ½éšœå®³æ‚£è€…ã€é«˜é½¢è€…ã€ã¦ã‚“ã‹ã‚“æ‚£è€…ãŠã‚ˆã³ç—™æ”£ã®ãƒªã‚¹ã‚¯ãŒã‚ã‚‹æ‚£è€…ã€å°¿é–‰ã®å…ˆè¡Œè¦å› ï¼ˆè„Šé«„ç—…å¤‰ã€å‰ç«‹è…ºè‚¥å¤§ç—‡ï¼‰ãŒã‚ã‚‹æ‚£è€…ã¯ã€åŒ»å¸«ã¾ãŸã¯è–¬å‰¤å¸«ã«ã”ç›¸è«‡ãã ã•ã„ã€‚